IMMUNITYBIO, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 143.2% | 143.2% | -74.0% |
| FY2022 | 93.1% | 93.1% | -115.0% |
| FY2023 | 99.4% | 99.4% | -115.6% |
| FY2024 | 84.6% | 84.6% | -108.0% |
| FY2025 | 70.2% | 70.2% | -70.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 143.2% | 143.2% | -74.0% |
| FY2022 | 93.1% | 93.1% | -115.0% |
| FY2023 | 99.4% | 99.4% | -115.6% |
| FY2024 | 84.6% | 84.6% | -108.0% |
| FY2025 | 70.2% | 70.2% | -70.0% |